GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PhotoCure ASA (OTCPK:PHCUF) » Definitions » Ending Cash Position

PhotoCure ASA (PhotoCure ASA) Ending Cash Position : $24.34 Mil (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is PhotoCure ASA Ending Cash Position?

PhotoCure ASA's Ending Cash Position for the quarter that ended in Mar. 2024 was $24.34 Mil.

PhotoCure ASA's quarterly Ending Cash Position increased from Sep. 2023 ($23.78 Mil) to Dec. 2023 ($24.60 Mil) but then declined from Dec. 2023 ($24.60 Mil) to Mar. 2024 ($24.34 Mil).

PhotoCure ASA's annual Ending Cash Position declined from Dec. 2021 ($35.95 Mil) to Dec. 2022 ($27.13 Mil) and declined from Dec. 2022 ($27.13 Mil) to Dec. 2023 ($24.60 Mil).

PhotoCure ASA Ending Cash Position Historical Data

The historical data trend for PhotoCure ASA's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PhotoCure ASA Ending Cash Position Chart

PhotoCure ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.89 38.46 35.95 27.13 24.60

PhotoCure ASA Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.36 23.98 23.78 24.60 24.34

PhotoCure ASA Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

PhotoCure ASA's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=25.411+-0.812
=24.60

PhotoCure ASA's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=24.454+-0.117
=24.34

PhotoCure ASA Ending Cash Position Related Terms

Thank you for viewing the detailed overview of PhotoCure ASA's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

PhotoCure ASA (PhotoCure ASA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PhotoCure ASA (OTCPK:PHCUF) » Definitions » Ending Cash Position
Comparable Companies
OSL:VISTN ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692 NSE:DIVISLAB BOM:500124 VTRS NBIX SZSE:000963 SHSE:600085 XPAR:IPN SHSE:600196 XTAE:TEVA
Traded in Other Exchanges
PHOO:Sweden PHO:Norway 0IMT:UK
Address
Hoffsveien 4, Oslo, NOR, 0275
Website
https://www.photocure.com
PhotoCure ASA is a Norway-based business group associated with the research, development, production, distribution, marketing, and sales of pharmaceutical products specialty pharmaceutical companies. Its technology platform is focused on the field of photodynamic diagnosis and treatment of cancer. It has two operating segments of the group the Commercial franchise and the Development portfolio. It generates prime revenue from the Commercial franchise segment, which includes Hexvix and Cysview products. Its geographical segments are Nordic countries, Germany, France, Austria, the United Kingdom, Netherlands, Other European countries, and the United States.